Search for semaglutide
As the obesity epidemic grows, interventions to mitigate related health complications become increasingly important. In recent years, using medicines off-label for weight loss has become an appealing option for many people. Yet just how wide-spread people's interests are, and what the nature of interest in such options is, is relatively unknown.
Changing lifestyle and diet is recognised for achieving better outcomes for a range of non-communicable diseases, including diabetes. The global burden of diabetes is significant [1], giving rise to the development of pharmaceutical interventions to tackle this epidemic [2]. Semaglutide is an insulin production-targeting drug intended to treat people with diabetes by inducing weight loss [3]. However, the use of this prescribed medication is increasingly being considered in non-medical contexts and especially promoted on social media. Indeed, social media influencers who are endorsing the use of this medicine are suggested to have contributed towards recent worldwide shortages in semaglutide [4].
What inspired this study?
There are a host of medical and non-medical-related factors driving the supply and demand of medicines for weight loss. The interest in off-label use of semaglutide will likely vary between countries and given the far-reaching access to the internet, people’s perspectives on semaglutide can be captured from nations across the globe. The internet is therefore a useful resource in understanding the international viewpoint on semaglutide and Dr Raubenheimer (the lead author for this research) and his co-authors aimed to explore online behaviours to help explain the drivers (often non-clinical) behind the increasing interest in this product.
Why is it important?
A healthy lifestyle can contribute towards prolonging life, preventing disease and reducing economic burdens on healthcare systems. However, maintaining a healthy lifestyle can be challenging—quick fixes become more alluring. This study helps to understand why the use off-label medicine for weight loss (like semaglutide) is of interest across a range of populations, where people’s motives may be influenced by a host of environmental, social and situational factors. Understanding patterns of interest in semaglutide usage may help explain recent shortages in supplies of the drug and conceptualise interventions to prevent this happening again.
Did this study show anything unexpected?
Dr Raubenheimer and colleagues conducted an infodemiology study (a type of epidemiological study using data from internet searches [5]) of Google Trends related to semaglutide between Janurary 2021 and August 2023. The findings highlight some countries where there was increased interest in semaglutide, although media coverage only partly explained the interest. There were specific media and social media events of note that the authors indicated to spike online interest in semaglutide across numerous countries, including an episode of the Dr Oz Show and tweets from Elon Musk. Dr Raubenheimer’s team thematically analysed the Google Trends data, highlighting that weight loss (but not diabetes) was a major theme across most countries related to searches for semaglutide. Interest in many countries was also dominated by searches on how to obtain semaglutide.
What is the wider significance of the study findings?
The study illuminates the potential power of the internet in exploring what drives people's interests to search for information about medicinal weight loss interventions. The trends identified in different countries may elucidate specific drivers underlying the increased interest in semaglutide, which may be attributed to off-label use for non-clinical purposes. The subsequent shortage in semaglutide, potentially as a consequence of the rapidly growing interest online, may prevent these medicines reaching those who need it most. Furthermore, supply and demand challenges may increase the production of counterfeit and unregulated medicines flooding the markets, further exacerbating the problem.
References
- World Health Organization (WHO). The top 10 causes of death. Fact Sheets. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 19 May 2023.
- Khan N. How to ‘drug’ our way out of the obesity crisis (or not): the roll-out of semaglutide. Br J Gen Pract. 2024;74:218–218.
- Walmsley R, Sumithran P. Current and emerging medications for the management of obesity in adults. Med J Aust. 2023;218:276–83.
- Therapeutic Goods Administration (TGA). About the Ozempic (semaglutide) shortage 2022 and 2023. Therapeutic Goods Administration (TGA). 2022. https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-ozempic-semaglutide-shortage-2022-and-2023. Accessed 12 Feb 2024.
- Eysenbach G. Infodemiology and Infoveillance: Tracking online health information and cyberbehavior for public health. Am J Prev Med. 2011;40:S154–8.
Follow the Topic
-
BMC Global and Public Health
An open access, transparent peer review journal publishing outstanding and influential research and opinion of broad interest to all professional communities involved in global and public health research, policy-making, implementation and delivery worldwide.
Related Collections
With collections, you can get published faster and increase your visibility.
Evolving implementation science concepts and methods in low- and middle-income countries
BMC Global and Public Health is calling for submissions to our Collection on implementation science in low- and middle-income countries (LMICs). Implementation science, crucial for achieving health-related United Nations Sustainable Development Goals, focuses on bridging the gap between evidence-based practices and their real-world application by practitioners and policymakers. This interdisciplinary approach aims to maximize the impact of evidence-informed interventions, acknowledging the contextual differences between high-income countries (HIC) and low- and middle-income countries. While theories and frameworks from HIC may not directly apply to LMIC contexts, there is a need to amplify insights from LMIC implementation science studies to ensure progress towards global health goals.
Health interventions would never reach their expected impact unless wisely implemented. Implementation science refers to the study of methods that facilitate the uptake of evidence-based practice into regular use by practitioners and policymakers and is increasingly recognized as important for achieving health-related United Nations Sustainable Development Goals (SDGs). It seeks to close the gap between what is known and what to do, thus improving health services and outcomes through an interdisciplinary approach. Successful implementation strategies could maximize the beneficial impact of evidence-informed interventions (including programs, policies, and practices) at scale in real-world contexts. Given the extent to which context shapes implementation, implementation science may be highly contextualized, and concepts, principles, and methods from one setting may not be readily transportable to another. This should be considered when comparing implementation science studies from high-income countries (HIC) and low- and middle-income countries (LMIC). This is why certain implementation science theories, models, and frameworks developed in HIC are only readily applicable in LMIC with further adaptations. However, inherent publication biases that advantage academic cultures, philosophies, and systems from HIC have limited the visibility of implementation science studies from LMIC and insights into how the field has differentially evolved in LMIC, where more progress for achieving the UN SDGs is still needed.
The limited insights from LMIC may have further impacted our understanding of how implementation science can be applied to achieve health equity – since addressing health inequities is a major priority in resource-limited settings, where most of the LMIC population resides.
To capture global efforts and novel approaches in this multidisciplinary area, BMC Global and Public Health is pleased to announce a call for papers for our upcoming Collection entitled ‘Evolving implementation science concepts and methods in low- and middle-income countries’, guest edited by Dr Olakunle Alonge, from the Sparkman Center for Global Health, School of Public Health, University of Alabama at Birmingham, USA and Dr Meredith B. Brooks, PhD, MPH, from the Boston University School of Public Health, USA.
We are now inviting the submission of manuscripts of outstanding interest covering the breadth of multidisciplinary studies, including quantitative, qualitative, mixed-methods, and multi-methods studies that apply concepts and methods from implementation science to improve health services and outcomes, especially health equity, in LMICs. We envision this work advancing the growth of the field of implementation science globally.
We encourage submissions that address the following themes:
New concepts, theories, or frameworks for implementation science in LMIC contexts
New methodology that advances implementation evaluation and mechanisms investigation
Implementation trials and hybrid implementation-effectiveness trials for public health intervention
Pilot/feasibility studies of full-scale implementation projects
Studies of adaptation and implementation of evidence-based public health interventions in LMIC
Explorations of sociocultural factors for successful implementation of public health projects
This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being and SDG 10: Reduced Inequalities.
We encourage work from local, regional, and global partnerships and collaboration among scientists from multidisciplinary fields using multiple methodologies. Please note that we are not able to consider studies that are too clinically focused. We further ask that authors be attentive to the use of non-stigmatizing/preferred language in their manuscripts as outlined in relevant language guidelines for their respective fields.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 19, 2025
Making health care more accessible, acceptable, and sustainable to migrants and refugees
BMC Global and Public Health is calling for submissions to our Collection on accessible, acceptable, and sustainable health care for migrants and refugees. Migration, referring to the movement of people from one place to another, either across or within state borders, is a complex and multifaceted phenomenon. It can occur due to various factors, including economic opportunities, persecution, war, conflict, and environmental changes. Mass migration poses significant challenges to the health and well-being of migrants and refugees, as they often face barriers to accessing quality healthcare services and are at increased risk of physical and mental health issues.
In October 2023, the World Health Organization (WHO) published its first-ever global research agenda on health, migration and displacement. The agenda prioritized the generation of evidence on inclusive universal health coverage and primary health care among these unresearched groups. It was also highlighted that multisectoral research is needed to address the determinants of health for migrant populations. By strengthening equitable and inclusive research collaborations, novel evidence and knowledge obtained could hopefully be translated into policy and practice that improve health and healthcare services for migrant populations.
In response to this global research agenda and to capture global efforts and novel approaches in this multi-disciplinary area, BMC Global and Public Health is pleased to announce a call for papers for our upcoming collection entitled ‘Making health care more accessible, acceptable and sustainable to migrants and refugees', guest edited by Dr. Wen Chen, from the School of Public Health, Sun Yat-sen University, China.
This call for papers seeks to advance our understanding of the health needs and experiences of migrants and refugees and the strategies and approaches that can make health care more accessible, acceptable, and sustainable for migrants and refugees.
We are now inviting the submission of manuscripts of outstanding interest covering the breadth of multi-disciplinary studies, ranging from observational to interventional, that are focused on migrant and refugee health and health care. We envision this work to inform future research, frameworks, intervention development, and policy.
We encourage submissions that address the following themes:
Health disparities and inequalities among migrants and refugees
Barriers to accessing healthcare systems for migrants and refugees
Mental health and psychosocial well-being of migrants and refugees
Infectious diseases and public health challenges in migrant and refugee populations
Innovative models and approaches of health care delivery for migrants and refugees
Policy and advocacy efforts to improve migrant and refugee health
We encourage work from local, regional, and global partnerships and collaboration among scientists from multi-disciplinary fields and the use of multiple methodologies. We ask that authors be attentive to the use of non-stigmatizing/preferred language in their manuscripts as outlined in relevant language guidelines for their respective fields.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 07, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in